Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.
In Fiscal 2021, the company's products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.
Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure. The company's manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.
Funds from the fresh issue will be used for
The Company will utilize fresh issue proceeds for the following:
Funding capital expenditure requirements of the company.
Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company.
General corporate purposes.
Company Financials: (in crores)
How to apply for an IPO/Buyback Online via Navjeevan?
Step 1: Go to our website and select an IPO that you wish to apply for.
Step 2: Log in your details (Non-Navjeevan Client can log in via their mobile number).
Step 2: Enter the price at which you want to apply for shares and the number of lots and provide your UPI ID
Step 4: Submit the application and then approve the block funds request on the UPI App.
Step 5: Done
Open: December 16, 2021 | Close: December 20, 2021